CD20+ T cells: an emerging T cell subset in human pathology
AYS Lee - Inflammation Research, 2022 - Springer
Introduction Although CD20 is classically a B cell marker, in the last three decades, dim
expression has been noted on a subset of T cells as well that has been independently …
expression has been noted on a subset of T cells as well that has been independently …
Toward overcoming treatment failure in rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune disorder characterized by inflammation and
bone erosion. The exact mechanism of RA is still unknown, but various immune cytokines …
bone erosion. The exact mechanism of RA is still unknown, but various immune cytokines …
Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting
Background Baricitinib is a JAK inhibitor that blocks intracellular signalling pathways of
inflammatory cytokines recommended for Rheumatoid arthritis (RA) patients not responding …
inflammatory cytokines recommended for Rheumatoid arthritis (RA) patients not responding …
T cells in ocular autoimmune uveitis: Pathways and therapeutic approaches
M Zhang, X Zhang - International immunopharmacology, 2023 - Elsevier
Autoimmune uveitis is a non-infectious intraocular condition that affects the uveal tract of the
eye and threatens vision if not treated properly. Increasing evidence suggests that activated …
eye and threatens vision if not treated properly. Increasing evidence suggests that activated …
[HTML][HTML] Pharmacogenomics of monoclonal antibodies for the treatment of rheumatoid arthritis
SH Lim, K Kim, CI Choi - Journal of Personalized Medicine, 2022 - mdpi.com
Precision medicine refers to a highly individualized and personalized approach to patient
care. Pharmacogenomics is the study of how an individual's genomic profile affects their …
care. Pharmacogenomics is the study of how an individual's genomic profile affects their …
Involvement of B cells in the development of systemic sclerosis
Systemic sclerosis (SSc) is a rare intractable systemic disease that causes fibrosis and
vasculopathy against a background of autoimmune abnormalities. Although the etiology is …
vasculopathy against a background of autoimmune abnormalities. Although the etiology is …
[HTML][HTML] Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment …
S Bejerot, SS Stein, E Welin, D Eklund, U Hylén… - Journal of Psychiatric …, 2023 - Elsevier
In this explorative study, we investigated if an adjunctive treatment with one single dose of
the monoclonal antibody rituximab would improve symptoms and function in treatment …
the monoclonal antibody rituximab would improve symptoms and function in treatment …
B cells in autoimmune hepatitis: bystanders or central players?
C Schultheiß, S Steinmann, AW Lohse… - Seminars in …, 2022 - Springer
B cells are central for the adaptive immune system to mount successful immune responses
not only as antibody producers but also as regulators of cellular immunity. These …
not only as antibody producers but also as regulators of cellular immunity. These …
The gene regulatory network controlling plasma cell function
S Trezise, SL Nutt - Immunological Reviews, 2021 - Wiley Online Library
Antibodies are an essential element of the immune response to infection, and in long‐term
protection upon re‐exposure to the same micro‐organism. Antibodies are produced by …
protection upon re‐exposure to the same micro‐organism. Antibodies are produced by …
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study
Background The risk of infectious complications among patients with pemphigus managed
by rituximab is yet to be precisely elucidated. Objectives To evaluate the risk of infections in …
by rituximab is yet to be precisely elucidated. Objectives To evaluate the risk of infections in …